SCHEMBL29133772

SCHEMBL29133772

Nc1cncc(-c2ccc3ncnc(NCCc4ccccc4)c3c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.57
CYP3A4 P08684 6/20 0.57
MAPK1 P28482 5/20 0.57
LMNA P02545 5/20 0.57
ALDH1A1 P00352 5/20 0.57
HSD17B10 Q99714 5/20 0.57
CLK4 Q9HAZ1 5/20 0.57
EGFR P00533 4/20 0.57
CYP2D6 P10635 4/20 0.57
HIF1A Q16665 4/20 0.57
CYP2C19 P33261 3/20 0.57
HTT P42858 2/20 0.57
USP2 O75604 2/20 0.57
APP P05067 1/20 0.57
CCNC P24863 1/20 0.56
CDKN1A P38936 1/20 0.56
CDK8 P49336 1/20 0.56
CDK19 Q9BWU1 1/20 0.56
DYRK1A Q13627 1/20 0.56
PIK3CA P42336 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17845960 0.89 CLK4 (0.72) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133726 0.85 MAPK1 (0.61) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133712 0.83 MAPK1 (0.55) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133756 0.83 MAPK1 (0.53) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL13912334 0.82 EGFR (0.76) MAPK1LMNAEGFRHTTAPP
SCHEMBL29133708 0.81 EGFR (0.82) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133707 0.81 IRAK4 (0.56) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133715 0.80 EGFR (0.59) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133747 0.79 PIK3CA (0.65) CYP1A2CYP3A4MAPK1LMNAALDH1A1
SCHEMBL29133700 0.79 DYRK1A (0.56) CYP1A2CYP3A4MAPK1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed